citicoline + piracetam

Brislife is a fixed-dose combination pharmaceutical product marketed by Atlina Life Sciences, primarily in the Indian market. It contains two active ingredients: citicoline (CDP-choline) and piracetam. Citicoline is a naturally occurring endogenous nucleoside that serves as an intermediate in the biosynthesis of structural phospholipids in neuronal membranes; as a therapeutic agent, it acts as a neuroprotectant by increasing phosphatidylcholine synthesis and improving cerebral metabolism. Piracetam is a cyclic derivative of GABA and a member of the racetam class of nootropics; it is thought to improve cognitive function by modulating neurotransmission (particularly glutamatergic and cholinergic systems) and enhancing membrane fluidity and microcirculation. The combination is typically indicated for the management of cognitive impairment associated with neurological conditions such as ischemic stroke, traumatic brain injury, and age-related memory loss.

Brand names

Brislife

Other names

CDP-choline + piracetam